Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000819225 | SCV000959872 | pathogenic | Xeroderma pigmentosum, group F; Cockayne syndrome; Fanconi anemia complementation group Q | 2018-07-26 | criteria provided, single submitter | clinical testing | Loss-of-function variants in ERCC4 are known to be pathogenic (PMID: 9580660). A gross deletion of the genomic region encompassing the full coding sequence of the ERCC4 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals with ERCC4-related disease. For these reasons, this variant has been classified as Pathogenic. |